Hemostasis II Flashcards

1
Q

Thrombin activity is determined by __ and __

A

activation and inactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the Inhibitors of the coagulation cascade in each color

A

R: B, Serpins
G: A, non Serpins
B: C, TM- protein C system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the inhibitor type of A, non-serpins?

A

Kunitz-type inhibitor:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe structure of A, non-serpins inhibitor?

A

red: AAs which fit into the active site of the protease
Enzyme-Inhibitor Complex: reversible, Key-lock-model-
No conformational change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

An example of non-serpins inhibitor?

A

TFPI is such an inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The role of Tissue Factor Pathway Inhibitor (TFPI)

A

1/ Inhibits the initiation of the cascade
2/ The only inhibitor which can also inhibit membrane-bound proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Kunitz-type Inhibitor, released from __ and ___

A

endothelial cells and platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Kunitz-type Inhibitor is reversible
-> There are ionic interactions between __ and __

A

the Kunitz-Domains (K) and the proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Kunitz-type Inhibitor
-> The role of Protein-S-binding

A

Protein S-binding enhances FXa-binding, which enhances FVIIa-binding, and both FXa and FVIIa will be inactivated in the TF/FVIIa/FXa-Complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Does Kunitz-type Inhibitor have a high or low affinity?

A

HIGH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Kunitz-type Inhibitor is present in low or high concentration?

A

LOW CONCENTRATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A, non-Serpins, No2: a2-Macroglobulin stericly hinders protease activity
-> Structural features?

A

-inhibits thrombin, plasmin, kallikrein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Serpins?

A

Serine-protease-Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The role of Serpins

A

regulate many Ser-Proteases, and thereby many processes: Hemostasis, digestion, complement system- inflammation, ECM remodelling in embryonal development, cancer metastasis, tissue repair, apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Serpins cause reversible or irreversible inhibition.
-> Why?

A

Irreversible inhibition: enzyme cleaves the inhibitor, just like a substrate, but the hydrolysis of the acyl-enzyme intermediate is rather slow (weeks…)- irreversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The role of Serpins in hemostasis:

A

Antithrombin – Thrombin, (FXa, (FIXa)) – target of heparin therapy Heparin cofactor II – Thrombin
a1-Protease Inhibitor – Trypsin, elastase, thrombin

17
Q

3 steps of The TM-protein C-pathway

A

1, thrombomodulin (TM) on the surface of healthy endothelial cells

2, Thrombin binds to TM-via exosite I – specificity of thrombin changes: cleaves Protein C to activated Protein C (APC), instead of the other substrates

3, APC inactivates Va and VIIIa to Vi and VIIIi

18
Q

What is the most important endogenous anticoagulant mechanism?

A

Membrane-bound enzyme complexes in hemostasis
-> The TM-protein C-pathway

19
Q

Symtomps of Deep venous thrombosis/DVT

A

Most frequently in the legs,
-swelling, blocked venous blood flow
-lung emboli
– severe complication multifactorial
-Virchow-Triad

20
Q

What is Virchow-Triad?

A

1, enhanced blood clottability,
2, disturbed blood flow,
3, endothelial cell damage

21
Q

Anticoagulants applied in DVT
-> What are Anticoagulants for indirect inhibition?

A

Heparins: UFH, LMWH, fondaparinux
Vitamin K-antagonists (VKA):

22
Q

Anticoagulants applied in DVT
-> What are Anticoagulants for Direct inhibition?

A
  • Hirudin et al: block the active site of thrombin
  • DOAC/(NOAC): direct/(novel) oral anticoagulants
23
Q

Anticoagulants applied in DVT
-> What is the role of Heparins: UFH, LMWH, fondaparinux?

A

Work with Antithrombin together, accelerate the inactivation of thrombin by antithrombin

24
Q

Anticoagulants applied in DVT
-> What is the role of Vitamin K-antagonists (VKA)?

A

Inhibit the formation of Gla-domains, and thereby the assembly of membrane- bound activation complexes – slower thrombin generation

25
Q

What is Heparin?

A

a sulfated glucosaminoglycan

26
Q

How does Heparin work?

A

Heparin binds both thrombin and antithrombin and accelerates the inactivation of thrombin by antithrombin (4000X!).

At the end of the reaction is heparin regenerated, so it is a catalysator

27
Q

What is the minimal motif for heparin action?

A

Pentasaccharide

28
Q

UFH (unfractionated heparin) isolated from ___

A

porcine intestinal mucosa

29
Q

What are problems of UFH (unfractionated heparin)?

A

UFH is heterogenous, varying efficiency and elimination rate, and of animal origin - immunogenic

30
Q

What are some derivatives of heparin

A
31
Q

What is the Target of the vitamin K antagonists?

A

Vitamin K-oxidoreductase

32
Q

What are Pitfals of the vit K-antagonists?

A

Drug interactions, diet-dependent (Vit-K-content). Individual elimination rate

Contraindicated in pregnancy, because it could interfere with fetal bone development

33
Q

How can the vit K-antagonists act on gene expression?

A
  • Slow turn-on (days)
  • Slow turn-off (days) – factors must be re-synthesized
34
Q

Molecular signs of “coumarin-necrosis”?

A

Protein C and S fall out first
(life-time: 8-24 h vs Prothrombin: 3-5 days)
- Transient prothrombotic state – heparin should be given first, followed by the VKAs

35
Q

What is Hirudin?

A

Direct Thrombin-inhibitors

36
Q

Characteristics of Direct Thrombin-inhibitors I. Hirudin

A

Binds like heparin+antithrombin
“too effective” – bleeding is frequent

37
Q

Characteristics of Direct Thrombin-, and Xa - inhibitors II.

A

(DOAC: direct oral Anticoagulants:)

-per os (tablets), small reversible inhibitors blocking the active site -quick, short-lived, Antidotum exists,
- No need for regular monitoring
-bleeding frequency is ca 1/3 of the VKAs
-much more expensive, than VKA

38
Q

Symptoms of Hemophilia

A

Unexplained and excessive bleeding from cuts or injuries, or after surgery or dental work.

Many large or deep bruises.

39
Q

Hemophilia
-> Why do they bleed?

A

Amplification of thrombin generation falls out